Psoriatic Arthritis Trial, Recruiting NCT07653009 Sponsor: Marmara University Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT07653009
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with psoriatic arthritis using a specific set of medical criteria called the CASPAR criteria
  • People who are between 18 and 65 years old
  • People whose current treatment plan has remained unchanged for at least 12 weeks before joining the trial
  • People who rate their pain at 4 or higher on a scale of 0 to 10
  • People whose psoriatic arthritis is considered moderately to highly active, based on a scoring tool called the DAPSA
  • People who are able and willing to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have an implanted heart device, such as a pacemaker or defibrillator, or an implanted nerve stimulator
  • People with a history of epilepsy or other neurological conditions that are not well controlled
  • People who have a serious active infection or a condition that severely weakens the immune system, such as sepsis
  • People who are pregnant or breastfeeding
  • People who have a deep injury inside the ear, have had previous ear surgery, or have active skin problems affecting the outer ear
  • People who may have difficulty following the trial's treatment schedule, or who have a history of severe psychiatric disorders

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Halise Hande Gezer, MD, Associate Professor, Marmara University Faculty of Medicine

Phone: +90 533 485 59 11

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
2 June 2026
Est. completion
2 June 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in Disease Activity According to Disease Activity Index for Psoriatic Arthritis (DAPSA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov